Mounjaro 7.5 Mg/0.6ml Kwikpen is a once-weekly injection designed for adults with type 2 diabetes, FDA approved to effectively lower blood sugar levels. While it may assist in weight loss, it is not FDA approved for this use. This medication works by increasing insulin production and reducing sugar production in the liver.
Key Features
- Storage: Keep refrigerated between 36°F to 46°F (2°C to 8°C).
Benefits
- Reduces blood sugar levels effectively.
- May help with weight loss (not FDA approved).
- Increases insulin production in the body.
- Lowers sugar production in the liver.
- Slows food passage to enhance feelings of fullness.
Side Effects
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Upset stomach
Serious Side Effects
- Thyroid C-cell tumors
- Hypoglycemia
